Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records)
|Query Trace: Lung Neoplasms and SLC31A1[original query]|
| Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation.
Oncotarget 2018 May 9 (35): 23860-23877.
Sun Chang, Zhang Zhuojun, Qie Jingbo, Wang Yi, Qian Ji, Wang Jiucun, Wu Junjie, Li Qiang, Bai Chunxue, Han Baohui, Gao Zhiqiang, Xu Jibin, Lu Daru, Jin Li, Wang Haiji
| A pharmacogenetics study of platinum-based chemotherapy in lung cancer: ABCG2 polymorphism and its genetic interaction with SLC31A1 are associated with response and survival.
Journal of Cancer 2021 2 12 (5): 1270-1283.
Wang Liyan, Sun Chang, Li Xiangnan, Mao Chenxue, Qian Ji, Wang Jiucun, Wu Junjie, Li Qiang, Bai Chunxue, Han Baohui, Gao Zhiqiang, Xu Jibin, Yin Jiye, Liu Zhaoqian, Lu Daru, Jin Li, Wang Haiji
| Cuproptosis-Related Gene - SLC31A1, FDX1 and ATP7B - Polymorphisms are Associated with Risk of Lung Cancer.
Pharmacogenomics and personalized medicine 2022 15 733-742.
Yun Yuhui, Wang Yun, Yang Ende, Jing X
| Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types.
BMC medical genomics 2023 3 16 (1): 61.
Kong Fan-Sheng, Ren Chun-Yan, Jia Ruofan, Zhou Yuan, Chen Jian-Huan, Ma Yapi
- Page last reviewed:Feb 1, 2023
- Page last updated:May 22, 2023
- Content source: